NCT05719545

Brief Summary

To investigate the risk factors involved in the occurrence and prognosis of the patients with acute coronary syndrome, patients undergoing percutaneous coronary intervention will be recruited and followed up for at least 2 years.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Dec 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Dec 2021Dec 2026

Study Start

First participant enrolled

December 1, 2021

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

January 31, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 9, 2023

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

February 9, 2023

Status Verified

January 1, 2023

Enrollment Period

5.1 years

First QC Date

January 31, 2023

Last Update Submit

January 31, 2023

Conditions

Acute Coronary SyndromePercutaneous Coronary InterventionMyocardial InfarctionUnstable Angina

Outcome Measures

Primary Outcomes (1)

  • major adverse cardiovascular events

    all-cause mortality, cardiovascular mortality, ischemic stroke

    2-year outcome and long-term outcome

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with acute coronary syndrome undergoing percutaneous coronary intervention.

You may qualify if:

  • Diagnosed as acute coronary syndrome and needed to undergo percutaneous coronary intervention.
  • \>18 years old.

You may not qualify if:

  • With malignant tumors, acute infectious diseases and advanced liver diseases.
  • Won't sign an inform consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jinan Central Hospital

Jinan, Shandong, China

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

blood and fecal samples

MeSH Terms

Conditions

Acute Coronary SyndromeMyocardial InfarctionAngina, Unstable

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisAngina PectorisChest PainPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Guohao Su, doctor

    Jinan Central Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Guohai Su, doctor

CONTACT

+86-18854125717huangrong9277@163.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 31, 2023

First Posted

February 9, 2023

Study Start

December 1, 2021

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

February 9, 2023

Record last verified: 2023-01

Locations

CN(1)